|
|
- |
Molecular genetics of cell death in cancer |
| James Amatruda |
- |
Defining novel cancer genes and understanding the developmental biology of tumors using the zebrafish system |
| Robert Bachoo |
- |
Neuro-Oncology |
| David Boothman |
- |
Low dose radiation and cancer |
| Rolf A. Brekken |
- |
Tumor-host interactions in pancreatic cancer |
James Brugarolas |
- |
Mechanisms of tumor development; hypoxia signaling; molecularly targeted cancer therapies; research translation; tuberous sclerosis complex and mTOR pathways; renal cell carcinoma |
|
Richard Bruick
|
- |
Regulation of the mammalian hypoxic response pathway in cancer |
| Sandeep Burma |
- |
Recognition, signaling, and repair responses mounted by DNA-PK and ATM upon DNA damage inflicted by terrestrial radiation (X-rays and gamma rays) as well as by radiation in outer space (HZE particles) |
| Scott Cameron |
- |
lineages and programmed cell death |
| Diego Castrillon |
- |
PI3K / PTEN / AKT / FoxO pathways in cancer biology |
| David Chen |
- |
Radiation biology and DNA damage signaling |
| Melanie H. Cobb |
- |
Function and regulation of protein kinases in signal transduction pathways in breast cancer |
| David R. Corey |
- |
Cancer therapeutics: Engineering proteins and nucleic acids for novel function |
Jef De Brabander |
- |
Synthesis of natural products and other molecular architectures and interrogation of their mode-of-action using molecular pharmacology and biochemistry for the development of novel cancer therapeutics |
| Errol C. Friedberg |
- |
Cellular responses to DNA damage in eukaryotic cells with emphasis on cancer-prone human hereditary diseases |
| Jinming Gao |
- |
Cancer nanomedicine; targeted drug/siRNA delivery; cancer molecular imaging |
| Harold R. (Skip) Garner, Jr. |
- |
Automation and instrumentation for genomics research; DNA sequence analysis; computational biology |
| Robert E. Hammer |
- |
Transforming growth factor beta signaling |
| Jer-Tsong (J.T.) Hsieh |
- |
Human cancer gene therapy; signaling defects in urogenital cancers |
Lily Huang |
- |
Cytokine receptor; signal transduction; hematopoiesis; structure-function analysis of protein; cancer |
| Jin Jiang |
- |
Signal-transduction pathways in development and human disease; genetic control of organ growth and patterning; tumor suppressor genes |
| Beth Levine |
- |
Role of autophagy in tumor suppression |
| Qing Richard Lu |
- |
Differentiation mechanisms in the mammalian central nervous system: gliogenesis as a model |
| Lawrence Lum |
- |
How information from multiple signaling molecules, including Hh and Wg, integrate in developmental and cancer |
| Ralph Mason |
- |
Animal imaging in cancer |
| Steven McKnight |
- |
Molecular genetics and biochemical studies of mammalian gene regulation. |
John Minna |
- |
Molecular genetics of human cancer; development of molecular assays for early detection, prediction of response to therapy, and new targeted therapies for human cancer; growth factors and signal transduction in human tumors |
| Jerry Y. Niederkorn |
- |
Immune surveillance of intraocular tumors; immune modulation of cancer metastases |
| Luis F. Parada |
- |
Mechanisms of neural development; trk receptors and neurotrophins; mouse models of neurological tumors |
| Alexander Pertsemlidis |
- |
microRNA regulation of cell proliferation, cell death and
tumorigenesis |
| Matthew Porteus |
- |
Regulation of DNA double-stranded break repair; regulation of homologous recombination in cancer |
| Michael Roth |
- |
High throughput screening for novel cancer therapeutics. Recognition and sorting of cell-surface glycoproteins |
| Pier Paolo Scaglioni |
- |
Characterization of the function of the PML tumor suppressor, mechanisms of K-RAS induced tumorigenesis, role of oncogene induced replicative senescence in tumor suppression, mouse models of lung cancer |
| Richard H. Scheuermann |
- |
Regulation of immunoglobulin gene expression; regulation of lymphocyte growth, development and apoptosis; lymphocyte receptor signal transduction; technology development; novel approaches to cancer therapy |
| Roger A. Schultz |
- |
Human genome instability, including Bloom and Roberts syndromes, centromere structure and function, and molecular evolution chromosome structure |
| Jerry Shay |
- |
Molecular mechanisms of human cellular aging and immortalization; the role of telomeres and telomerase in cancer |
| Michael Story |
- |
Radiation biology of cancer, genomics |
| Philip Thorpe |
- |
Development of novel angiogenesis inhibitors and agents for inducing thrombosis of tumor blood vessels for cancer treatment |
| Jonathan Uhr |
- |
Improving cancer treatment through: diagnosis at an earlier stage; analysis of cancer dormancy at the cellular and molecular levels; and targeted killing of human cancer cells in SCID mice by treatment with cell reactive monoclonal antibodies |
| Ellen S. Vitetta |
- |
The targeting of cytotoxic reagents to lymphoid cancers |
| Xiaodong Wang |
- |
Biochemistry of mammalian apoptosis, chemical synthesis of inhibitors of apoptosis for cancer therapy |
| Michael White |
- |
Molecular mechanisms for control of cell growth and differentiation |
| Woodring E. Wright |
- |
The role of telomeres and telomerase in cellular senescence and cancer |
| Hongtao Yu |
- |
Study of cell division cycle |
| Yingming Zhao |
- |
Functional proteomics and mass spectrometry in cancer |
| Hui Zou |
- |
Misregulation of chromatid cohesion and separation in cancer |
| |
|
|
| Back to Top |
|
Contact the webmaster with questions or concerns. |